Who is the founder of Pfizer?

German emigrants Charles Pfizer and his cousin Charles F. Erhart founded Pfizer in New York City in 1849. They launched the chemicals business, Charles Pfizer and Company, at Bartlett Street in Williamsburg, Brooklyn, where they produced an antiparasitic called santonin.

How much did Pfizer spend to acquire Hospira?

“Pfizer Bets $15 Billion on New Class of Generic Drugs”. The New York Times. ^ “8-K”. U.S. Securities and Exchange Commission. February 6, 2015. ^ “Pfizer to Acquire Hospira”. Pfizer (Press release). ^ Neilan, Catherine (February 5, 2015). “Pfizer, Hospira share prices to soar after $17bn deal announced”. City A.M.

What does Pfizer’s merger with Pfizer mean for the world?

The deal cemented Pfizer’s position as the largest pharmaceutical company in the world, with the merged company generating over US$20 billion in cash each year, and was the largest corporate merger since AT and BellSouth’s US$70 billion deal in March 2006.

How much did Pfizer spend on the new class of drugs?

“Pfizer Bets $15 Billion on New Class of Generic Drugs”. The New York Times. ^ “8-K”. U.S. Securities and Exchange Commission.

How much did Pfizer pay for fraudulent marketing?

Pfizer to Pay $2.3 Billion for Fraudulent Marketing. WASHINGTON – American pharmaceutical giant Pfizer Inc. and its subsidiary Pharmacia & Upjohn Company Inc. (hereinafter together “Pfizer”) have agreed to pay $2.3 billion, the largest health care fraud settlement in the history of the Department of Justice, to resolve criminal

What happened to King Pharmaceuticals and Pfizer?

In February 2011, Pfizer announced the closure of its UK research and development facility (formerly also a manufacturing plant) in Sandwich, Kent, which at the time employed 2,400 people. In March 2011, Pfizer acquired King Pharmaceuticals for $3.6 billion in cash. King produced emergency injectables such as the EpiPen.

Why did Pfizer and Pharmacia merge?

In 2002, Pfizer merged with Pharmacia. The merger was again driven in part by the desire to acquire full rights to a product, this time Celebrex (celecoxib), the COX-2 selective inhibitor previously jointly marketed by Searle (acquired by Pharmacia) and Pfizer.